Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial
Paul Nankivell,
Piers Gaunt,
Claire Gaunt,
Julia Sissons,
Evaggelia Liaskou,
Yolande Jefferson,
Tessa Fulton-Lieuw,
Saloni Mittal,
Hisham Mehanna,
PETNECK2 Research Team
Affiliations
Paul Nankivell
Institute of Head and Neck Studies and Education (InHANSE), Institute of Cancer and Genomic Sciences, University of Birmingham
Piers Gaunt
Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
Claire Gaunt
Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
Julia Sissons
Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
Evaggelia Liaskou
Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
Yolande Jefferson
Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
Tessa Fulton-Lieuw
Institute of Head and Neck Studies and Education (InHANSE), Institute of Cancer and Genomic Sciences, University of Birmingham
Saloni Mittal
Institute of Head and Neck Studies and Education (InHANSE), Institute of Cancer and Genomic Sciences, University of Birmingham
Hisham Mehanna
Institute of Head and Neck Studies and Education (InHANSE), Institute of Cancer and Genomic Sciences, University of Birmingham